Mohty M, Gaugler B
Laboratoire d'Immunologie des Tumeurs, Institut Paoli-Calmettes, Marseille, France.
Leukemia. 2003 Sep;17(9):1753-8. doi: 10.1038/sj.leu.2403049.
Dendritic cells (DCs) are the most potent antigen-presenting cells in vitro and in vivo. They play a key role in the initiation of the immune response and are considered promising targets for immunotherapy. The recent DC Keystone Symposia, organized by Ralph M Steinman, Anne O'Garra and Jacques Banchereau, was held on 3-8 March 2003 in Keystone (CO, USA). This multidisciplinary meeting developed various areas related to the DC biology including: (i) DC and the control of immunity vs tolerance; (ii) DC maturation and manipulation for immunotherapy in vivo; and (iii) antigen capture by DC in situ and interactions with microbial pathogens. The aim of this report is to present some of the highlights developed during the meeting and debated among the DC community.
树突状细胞(DCs)是体外和体内最有效的抗原呈递细胞。它们在免疫反应的启动中起关键作用,被认为是免疫治疗的有前景的靶点。最近由拉尔夫·M·斯坦曼、安妮·奥加拉和雅克·班克雷欧组织的树突状细胞研讨会于2003年3月3日至8日在美国科罗拉多州基斯通举行。这次多学科会议探讨了与树突状细胞生物学相关的各个领域,包括:(i)树突状细胞与免疫和耐受的控制;(ii)树突状细胞成熟及体内免疫治疗的调控;(iii)树突状细胞原位捕获抗原以及与微生物病原体的相互作用。本报告的目的是介绍会议期间产生的一些亮点,并在树突状细胞领域进行讨论。